Please: Login/Register

The Latest Edition of "Eyes on malaria" magazine will be out very soon!! | CALL FOR ARTICLES: AMMREN is inviting journalists / writers / scientists interested in reporting on malaria to send articles for publication in its international magazine “Eyes on Malaria” and for posting on its website. Please contact the AMMREN Secretariat for more details click here. Enjoy your stay!. Volunteers and interns urgently needed to work with an NGO working in the area of malaria and health. Apply through - / Journalists interested in reporting on and writing articles on health issues should please reply through this email:




    Mosquitoes around the home can be reduced significantly by minimizing the amount of standing water available for mosquito breeding. Residents are urged to reduce standing water around the home in a variety of ways.


    The best way is to avoid being bitten by mosquitoes.This can be accomplished using personal protecting  while outdoors when mosquitoes are present. Treated bed nets should be used sleeping. Mosquito repellent should be used when outdoor.


    Nearly half of the world’s population is at risk of getting malaria. Pregnant women are particularly at risk of malaria. Children under 5 years are at high risk of malaria.


  • First Edition

  • Second Edition

  • Third Edition

  • Fourth Edition

  • Fifth Edition

  • Sixth Edition

  • Seventh Edition

  • Eighth Edition

  • Ninth Edition

  • Special Edition

  • INESS Edition

  • Tenth Edition

  • INDEPTH Edition

  • Eleventh Edition

  • Twelfth Edition

  • Special Edition

  • Special Edition

  • Volume 1

We’re Almost There, says MCTA’s Prof Fred Binka

There is no doubt that the whole of Africa is waiting with bated breath for the arrival of the vaccine which will save the lives of millions of children on the continent.

When the first vaccine trial results are announced in the course of the year, the Malaria Clinical Trials Alliance (MCTA) of the INDEPTH Network will be part of that celebration, having been in the forefront of the search for the vaccine that Africa has been expecting for so long.

The MCTA was established in 2006 with funding from the Bill and Melinda Gates Foundation to facilitate the development of capacity in Africa to conduct (Good Clinical Practice) trials for a malaria vaccine and drug interventions.

Under the able leadership of Prof Binka’s the MCTA has established and strengthened capacity of sites to carry out large scale vaccine and clinical trial sites.

Over the 5-year period, the MCTA was able to build the capacity of a critical mass of scientists to lead the search for a malaria vaccine. MCTA also collaborated with health regulatory authorities to review information produced from research sites and elsewhere to improve upon the health delivery system in Africa..

Professor Fred Newton Binka, the Project Manager says he feels fulfilled as the objectives project have been realized.

 MCTA has 11 sites in Africa, namely Ghana, Burkina Faso, Nigeria, Gabon, Gambia, Senegal, Kenya, Tanzania, Malawi and Mozambique. Most of the sites have expanded into centers of excellence that can be sustained and be able to conduct clinical trials successfully.

Professor Binka is confident of positive results of the malaria vaccine trials when they are released later this year.


     Prof Binka receiving the Ronald Ross award in London

        Prof Binka in a group picture at the awards ceremony

Africa has every reason to be proud Prof Binka, who has rightly been nicknamed by some as the “Mosquito Assassin.” It is not surprising that he has won many international awards in recognition of his passion to rid Africa of malaria and build the capacity of African scientist in carrying out clinical trials of strict international standards.

As MCTA bows out to make way for other initiatives, it leaves behind a legacy of a new crop of African scientists who are ready to ‘take’ malaria on and rid the continent of the menace

Sixth Edition